The implications of hyperoxia, type 1 diabetes and sex on cardiovascular physiology in mice

被引:5
作者
Bojkovic, Katarina [1 ]
Rodgers, Jennifer Leigh [1 ]
Vichare, Riddhi [1 ]
Nandi, Asmita [1 ]
Mansour, Hussein [1 ]
Saleem, Faizan [1 ]
Ul Abidin, Zain [1 ]
Vanthenapalli, Sahit [1 ]
Cheng, Feng [1 ]
Panguluri, Siva Kumar [1 ]
机构
[1] Univ S Florida, Dept Pharmaceut Sci, Coll Pharm, 12901 Bruce B Downs Blvd,MDC 30, Tampa, FL 33612 USA
关键词
INDUCED HYPERTROPHY; LUNG INJURY; TESTOSTERONE; MORTALITY; DISEASE; SPERMATOGENESIS; CARDIOTOXICITY; CELLS;
D O I
10.1038/s41598-021-02550-2
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Oxygen supplementation, although a cornerstone of emergency and cardiovascular medicine, often results in hyperoxia, a condition characterized by excessive tissue oxygen which results in adverse cardiac remodeling and subsequent injurious effects to physiological function. Cardiac remodeling is further influenced by various risk factors, including pre-existing conditions and sex. Thus, the purpose of this experiment was to investigate cardiac remodeling in Type I Diabetic (Akita) mice subjected to hyperoxic treatment. Overall, we demonstrated that Akita mice experience distinct challenges from wild type (WT) mice. Specifically, Akita males at both normoxia and hyperoxia showed significant decreases in body and heart weights, prolonged PR, QRS, and QTc intervals, and reduced %EF and %FS at normoxia compared to WT controls. Moreover, Akita males largely resemble female mice (both WT and Akita) with regards to the parameters studied. Finally, statistical analysis revealed hyperoxia to have the greatest influence on cardiac pathophysiology, followed by sex, and finally genotype. Taken together, our data suggest that Type I diabetic patients may have distinct cardiac pathophysiology under hyperoxia compared to uncomplicated patients, with males being at high risk. These findings can be used to enhance provision of care in ICU patients with Type I diabetes as a comorbid condition.
引用
收藏
页数:12
相关论文
共 50 条
[21]   Diabetes Medications and Cardiovascular Outcomes in Type 2 Diabetes [J].
Chi, Cecilia ;
Snaith, Jennifer ;
Gunton, Jenny E. .
HEART LUNG AND CIRCULATION, 2017, 26 (11) :1133-1141
[22]   Trials Review: Cardiovascular Outcome with Intensive Glycemic Control and Implications for Patients with Type 2 Diabetes [J].
Brown, Siobhan H. M. ;
Abdelhafiz, Ahmed H. .
POSTGRADUATE MEDICINE, 2009, 121 (05) :31-41
[23]   Impact of Obesity on Measures of Cardiovascular and Kidney Health in Youth With Type 1 Diabetes as Compared With Youth With Type 2 Diabetes [J].
Tommerdahl, Kalie L. ;
Baumgartner, Karl ;
Schafer, Michal ;
Bjornstad, Petter ;
Melena, Isabella ;
Hegemann, Shannon ;
Baumgartner, Amy D. ;
Pyle, Laura ;
Cree-Green, Melanie ;
Truong, Uyen ;
Browne, Lorna ;
Regensteiner, Judith G. ;
Reusch, Jane E. B. ;
Nadeau, Kristen J. .
DIABETES CARE, 2021, 44 (03) :795-803
[24]   Clinical implications of cardiovascular outcome trials in type2diabetes [J].
Mellbin, L. G. ;
Wang, A. ;
Ryden, L. .
HERZ, 2019, 44 (03) :192-202
[25]   Risk Factors for Cardiovascular Disease in Type 1 Diabetes [J].
Nathan, David M. ;
Bebu, Ionut ;
Braffett, Barbara H. ;
Lachin, John M. ;
Orchard, Trevor J. ;
Cowie, Catherine C. ;
Lopes-Virella, Maria ;
Schutta, Mark .
DIABETES, 2016, 65 (05) :1370-1379
[26]   Cardiovascular risk specificities in patients with type 1 diabetes [J].
Salle, L. .
CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2025, 29 (01)
[27]   Cardiovascular disease in type 1 diabetes: a continuing challenge [J].
Orchard, Trevor J. .
LANCET DIABETES & ENDOCRINOLOGY, 2021, 9 (09) :548-549
[28]   Blood Monocyte Phenotype Is A Marker of Cardiovascular Risk in Type 2 Diabetes [J].
Julla, Jean-Baptiste ;
Girard, Diane ;
Diedisheim, Marc ;
Saulnier, Pierre-Jean ;
Vuong, Bao Tran ;
Bleriot, Camille ;
Carcarino, Elena ;
De Keizer, Joe ;
Orliaguet, Lucie ;
Nemazanyy, Ivan ;
Potier, Charline ;
Khider, Kennan ;
Tonui, Dorothy Chepngenoh ;
Ejlalmanesh, Tina ;
Ballaire, Raphaelle ;
Mambueni, Hendrick Mambu ;
Germain, Stephane ;
Gaborit, Benedicte ;
Vidal-Trecan, Tiphaine ;
Riveline, Jean-Pierre ;
Garchon, Henri-Jean ;
Fenaille, Francois ;
Lemoine, Sophie ;
Carlier, Aurelie ;
Castelli, Florence ;
Potier, Louis ;
Masson, David ;
Roussel, Ronan ;
Vandiedonck, Claire ;
Hadjadj, Samy ;
Alzaid, Fawaz ;
Gautier, Jean-Francois ;
Venteclef, Nicolas .
CIRCULATION RESEARCH, 2024, 134 (02) :189-202
[29]   Sex Differences in the Association Between Cardiovascular Autonomic Neuropathy and Mortality in Patients With Type 2 Diabetes: The ACCORD Study [J].
Zhou, Ziwei ;
Huang, Yiquan ;
Zhuang, Xiaodong ;
Guo, Yue ;
Xie, Peihan ;
Xiong, Zhenyu ;
Liu, Menghui ;
Zhang, Wenjing ;
Zhong, Junqi ;
Li, Yi ;
Liao, Xinxue .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2025, 14 (02)
[30]   Sex inequalities in cardiovascular risk factors and their management in primary prevention in adults living with type 1 diabetes in Germany and France: findings from DPV and SFDT1 [J].
Cosson, Emmanuel ;
Auzanneau, Marie ;
Aguayo, Gloria A. ;
Karges, Wolfram ;
Riveline, Jean-Pierre ;
Augstein, Petra ;
Sablone, Laura ;
Jehle, Peter ;
Fagherazzi, Guy ;
Holl, Reinhard W. .
CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)